UNSPSC 51172159: Alverine hydrochloride

This classification denotes an anticholinergic agent with the molecular formula C20H27N.CLH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 8K3R1YUZ4I. Most nations, for tariff and trade purposes, schedule alverine hydrochloride under HS 29214980 and SITC 51454. As of Q4 2014, ALVERINE HYDROCHLORIDE remains US FDA's Preferred Term for this commodity. Alverine hydrochloride bears US NLM NCI C97966. SMILES: CCN(CCCC1CCCCC1)CCCC2CCCCC2.CL.

UNSPSC 51172159 Alveoline hydrochloride is a Commodity code that in recent state and local procurement activity covers pharmaceutical products supplied through authorized wholesaler networks and direct-to-state pharmacy benefit channels. State and local governments are buying generic pharmaceuticals, over-the-counter products, and specialized testing reagents and supplies through cooperative purchasing agreements and direct state health agency procurement. Issuing bodies include state health and human services agencies (Texas Health and Human Services Commission, Minnesota Department of Administration), county community supervision and corrections departments (Collin County), and multistate cooperative purchasing alliances (Minnesota Multistate Cooperative Purchasing Alliance, or MMCAP). The work encompasses establishing master agreements with pharmaceutical manufacturers and distributors to supply products to state agencies, county criminal-justice facilities, and participating local government entities across multiple jurisdictions.

Recent activity is concentrated in Texas and Minnesota. The Minnesota Multistate Cooperative Purchasing Alliance issued RFP S1070000015802 in January 2026 (proposals due March 26, 2026) for generic multi-source pharmaceuticals and OTC products to be supplied through AmerisourceBergen, Cardinal Health, and Morris & Dickson, with an effective date of July 1, 2026 and a two-year initial term. The Texas Health and Human Services Commission issued RFI HHS0017013 (posted March 27, 2026, response deadline April 3, 2026) to gather vendor capabilities for a Direct-to-Manufacturer Prescriptions program under the Therapeutic Pharmacy Initiative. Collin County Community Supervision and Corrections Department solicited offender specimen collection and drug testing services under RFP 2026-327 (due July 23, 2026), with an estimated contract value of $600,000 and an anticipated award date of August 10, 2026, covering immunoassay screening, confirmation testing, and alternative testing methodologies for approximately 25,031 annual tests across two collection sites.